News & Events
A new gene target for progressive MS
A mutation in a gene called NR1H3 could increase the risk of progressive MS
Mitoxantrone and risk of cancer in MS
German study asks whether recipients of mitoxantrone are more likely than the general population to develop cancers
Stem cell treatment halts MS progression
Rebooting immune system provides long term relief for aggressive relapsing MS in Canadian study
World MS Day makes an impact across the globe
From Canada to Pakistan people affected by MS raised their voices and raised awareness
ECTRIMS support for joint McDonald fellowship
Strengthening our collaboration with ECTRIMS
Second Scientific Congress of the International Progressive MS Alliance
Challenges and next steps considered
Rebound syndrome after stopping fingolimod
Researchers find that suddenly stopping fingolimod may lead to severe worsening of symptoms in MS
Use of metabolic syndrome drugs in multiple sclerosis
Drugs used for metabolic syndrome may reduce MS activity in people with MS and obesity
Bigger brains can protect against physical disability
Research suggests that higher brain growth is linked to lower risk for disability progression in people with…
Predicting long-term disability in MS
Australian researchers aim to predict future worsening of disability in people with relapse-onset MS
Canadian MS Society meets 75 MPs in 2 days
MS Society of Canada working hard to educate decision makers on MS
Simple adjustments could keep people with MS in work
Global MS Employment report highlights need for reasonable adjustments to help people with MS continue working.